178 related articles for article (PubMed ID: 17987111)
1. The R403Q myosin mutation implicated in familial hypertrophic cardiomyopathy causes disorder at the actomyosin interface.
Volkmann N; Lui H; Hazelwood L; Trybus KM; Lowey S; Hanein D
PLoS One; 2007 Nov; 2(11):e1123. PubMed ID: 17987111
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mouse α- and β-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences.
Lowey S; Bretton V; Gulick J; Robbins J; Trybus KM
J Biol Chem; 2013 May; 288(21):14780-7. PubMed ID: 23580644
[TBL] [Abstract][Full Text] [Related]
3. Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.
Lowey S; Lesko LM; Rovner AS; Hodges AR; White SL; Low RB; Rincon M; Gulick J; Robbins J
J Biol Chem; 2008 Jul; 283(29):20579-89. PubMed ID: 18480046
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
[TBL] [Abstract][Full Text] [Related]
5. Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.
Yamashita H; Tyska MJ; Warshaw DM; Lowey S; Trybus KM
J Biol Chem; 2000 Sep; 275(36):28045-52. PubMed ID: 10882745
[TBL] [Abstract][Full Text] [Related]
6. Point mutations in human beta cardiac myosin heavy chain have differential effects on sarcomeric structure and assembly: an ATP binding site change disrupts both thick and thin filaments, whereas hypertrophic cardiomyopathy mutations display normal assembly.
Becker KD; Gottshall KR; Hickey R; Perriard JC; Chien KR
J Cell Biol; 1997 Apr; 137(1):131-40. PubMed ID: 9105042
[TBL] [Abstract][Full Text] [Related]
7. Biological, biochemical, and kinetic effects of mutations of the cardiomyopathy loop of Dictyostelium myosin II: importance of ALA400.
Liu X; Shu S; Kovács M; Korn ED
J Biol Chem; 2005 Jul; 280(29):26974-83. PubMed ID: 15897189
[TBL] [Abstract][Full Text] [Related]
8. Functional consequences of mutations in the myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.
Lowey S
Trends Cardiovasc Med; 2002 Nov; 12(8):348-54. PubMed ID: 12536121
[TBL] [Abstract][Full Text] [Related]
9. R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level.
Palmiter KA; Tyska MJ; Haeberle JR; Alpert NR; Fananapazir L; Warshaw DM
J Muscle Res Cell Motil; 2000; 21(7):609-20. PubMed ID: 11227787
[TBL] [Abstract][Full Text] [Related]
10. Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.
Blanchard E; Seidman C; Seidman JG; LeWinter M; Maughan D
Circ Res; 1999 Mar; 84(4):475-83. PubMed ID: 10066683
[TBL] [Abstract][Full Text] [Related]
11. Contractility parameters of human β-cardiac myosin with the hypertrophic cardiomyopathy mutation R403Q show loss of motor function.
Nag S; Sommese RF; Ujfalusi Z; Combs A; Langer S; Sutton S; Leinwand LA; Geeves MA; Ruppel KM; Spudich JA
Sci Adv; 2015 Oct; 1(9):e1500511. PubMed ID: 26601291
[TBL] [Abstract][Full Text] [Related]
12. The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils.
Belus A; Piroddi N; Scellini B; Tesi C; D'Amati G; Girolami F; Yacoub M; Cecchi F; Olivotto I; Poggesi C
J Physiol; 2008 Aug; 586(15):3639-44. PubMed ID: 18565996
[TBL] [Abstract][Full Text] [Related]
13. Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.
Palmer BM; Fishbaugher DE; Schmitt JP; Wang Y; Alpert NR; Seidman CE; Seidman JG; VanBuren P; Maughan DW
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H91-9. PubMed ID: 15001446
[TBL] [Abstract][Full Text] [Related]
14. Evidence for cleft closure in actomyosin upon ADP release.
Volkmann N; Hanein D; Ouyang G; Trybus KM; DeRosier DJ; Lowey S
Nat Struct Biol; 2000 Dec; 7(12):1147-55. PubMed ID: 11101898
[TBL] [Abstract][Full Text] [Related]
15. The left and right ventricle of a patient with a R723G mutation of the beta-myosin heavy chain and severe hypertrophic cardiomyopathy show no differences in the expression of myosin mRNA.
Borchert B; Tripathi S; Francino A; Navarro-Lopez F; Kraft T
Cardiol J; 2010; 17(5):518-22. PubMed ID: 20865685
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyopathy-linked myosin regulatory light chain mutations disrupt myosin strain-dependent biochemistry.
Greenberg MJ; Kazmierczak K; Szczesna-Cordary D; Moore JR
Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17403-8. PubMed ID: 20855589
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the motor domain modulate myosin activity and myofibril organization.
Wang Q; Moncman CL; Winkelmann DA
J Cell Sci; 2003 Oct; 116(Pt 20):4227-38. PubMed ID: 12953063
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy.
Straceski AJ; Geisterfer-Lowrance A; Seidman CE; Seidman JG; Leinwand LA
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):589-93. PubMed ID: 8290568
[TBL] [Abstract][Full Text] [Related]
19. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
[TBL] [Abstract][Full Text] [Related]
20. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy.
Tyska MJ; Hayes E; Giewat M; Seidman CE; Seidman JG; Warshaw DM
Circ Res; 2000 Apr; 86(7):737-44. PubMed ID: 10764406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
